La Agencia Europea del Medicamento (EMA) y el Ministerio Japonés de Salud, Trabajo y Bienestar (MHLW) han lanzado una consulta […]
Blog
PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: Potential theranostic applications and in vivo toxicity studies – Uncorrected Proof
Abstract: Herein, we develop FePt@Fe2O3 core-shell magnetic nanoparticles as a T2 magnetic resonance (MR) imaging contrast agent as well as […]
Grifols adquiere el 60% del capital de Progenika Biopharma
El 4 de marzo del 2013 Grifols adquirió el 60% del capital de la biotecnológica vasca Progenika Biopharma por un […]
El proyecto Nanother concluye con el desarrollo de un nuevo método para la detección de tumores basado en nanopartículas
A finales de 2012 concluyó el proyecto NANOTHER, una investigación a nivel europeo que Gaiker ha liderado con el doble […]
Corrigendum to “A novel blood plasma analysis technique combining membrane electrophoresis with silver nanoparticle-based SERS spectroscopy for potential applications in noninvasive cancer detection” [Nanomed Nanotechnol Biol Med. 2011;7:655–663]
In Fig. 4 of the above-mentioned article, panels A, B, and C were the wrong data. The correct figure is […]
Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density
Abstract: Carboxylated (4%) multi-walled carbon nanotubes were covalently functionalized with poly(ethylene glycol)1000 (PEG1000), PEG1500 and PEG4000 with a PEG loading […]
Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups reveals negligible toxicity against three rodent cell-lines
Abstract: Modification of the surface groups of dendrimers is one of the methods to improve their biocompatibility. This article presents […]
Tissue and cellular localization of nanoparticles using 35S labeling and light microscopic autoradiography
Abstract: Microscopical visualization of nanoparticles in tissues is essential for assessing their distribution in whole organisms and their interaction with […]
Nuevas alianzas entre las farmacéuticas globales y start-ups expertas en liberación de nanofármacos
Durante las últimas semanas han tenido lugar la firma de acuerdos muy significativos entre dos de las grandes industrias farmacéuticas […]
Convocatoria EURONANOMED II Joint Translational Call 2013: “European Innovative Research & Technological Development Projects in Nanomedicine”
Después de tres exitosas convocatorias previas de Joint Translational Calls (2009-2011), en esta convocatoria 2013 la iniciativa EuroNanoMed ERA-NET cuenta […]